ClinicalTrials.gov
ClinicalTrials.gov Menu

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae (TEA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01543347
Recruitment Status : Withdrawn (No patient has been included in 9 months because of strict incl/excl criteria)
First Posted : March 5, 2012
Last Update Posted : January 29, 2013
Sponsor:
Information provided by (Responsible Party):
Belpharma s.a.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : November 2012